8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-15-000265
Results of operations · Other events
- Item 2.02 Results of operations and financial condition
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading v397974_8k.htm…